GlassScriptPhysician profile
Mina Ghassemi
NPI 1447747597
$417.26
in general payments reported to CMS, 2019-2025
13 companies · $85.41 in 2025
The $85.41 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.74 · 2021: $16.08 · 2022: $82.63 · 2023: $67.35 · 2024: $81.05 · 2025: $85.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $95.15 | 2022-2025 | Nuzyra |
| Osteomed LLC | $84.74 | 2020 | |
| Stryker Corporation | $39.42 | 2023 | Ortholoc 3di, Citrefix |
| Next Science LLC | $28.13 | 2024 | Surgx, Blastx, Xperience |
| Kerecis Limited | $26.34 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $23.10 | 2022 | |
| Orthofix Medical, INC. | $21.56 | 2022 | |
| Highridge Medical LLC | $19.73 | 2024 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $18.82 | 2025 | |
| Amgen INC. | $16.63 | 2025 | Krystexxa |
| Smith+Nephew, INC. | $16.08 | 2021 | |
| Paragon 28, INC. | $13.87 | 2023 | Gorilla |
| Ani Pharmaceuticals, INC. | $13.69 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Ghassemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.